Literature DB >> 15682358

One good turn deserves another.

Kenneth J Nichols, Olakunle O Akinboboye.   

Abstract

Mesh：

Year:  2005        PMID： 15682358     DOI： 10.1016/j.nuclcard.2004.11.001

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  13 in total

1.  Automated quantification of myocardial perfusion SPECT using simplified normal limits.

Authors:  Piotr J Slomka; Hidetaka Nishina; Daniel S Berman; Cigdem Akincioglu; Aiden Abidov; John D Friedman; Sean W Hayes; Guido Germano
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

2.  Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.

Authors:  D W Losordo; P R Vale; J F Symes; C H Dunnington; D D Esakof; M Maysky; A B Ashare; K Lathi; J M Isner
Journal:  Circulation       Date:  1998 Dec 22-29       Impact factor: 29.690

3.  Quantitative same-day rest-stress technetium-99m-sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality.

Authors:  K F Van Train; J Areeda; E V Garcia; C D Cooke; J Maddahi; H Kiat; G Germano; G Silagan; R Folks; D S Berman
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057

4.  Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients.

Authors:  E Van Belle; K Abolmaali; C Bauters; E P McFadden; J M Lablanche; M E Bertrand
Journal:  J Am Coll Cardiol       Date:  1999-08       Impact factor: 24.094

5.  Effects of long-term treatment with verapamil on left ventricular function and myocardial blood flow in patients with dilated cardiomyopathy without overt heart failure.

Authors:  D Neglia; G Sambuceti; A Giorgetti; M Bartoli; P Salvadori; O Sorace; G Puccini; A L'Abbate; O Parodi
Journal:  J Cardiovasc Pharmacol       Date:  2000-12       Impact factor: 3.105

6.  Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography.

Authors:  D S Berman; R Hachamovitch; H Kiat; I Cohen; J A Cabico; F P Wang; J D Friedman; G Germano; K Van Train; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1995-09       Impact factor: 24.094

7.  Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study.

Authors:  H A Dakik; N S Kleiman; J A Farmer; Z X He; J A Wendt; C M Pratt; M S Verani; J J Mahmarian
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

8.  Quantification of rotational thallium-201 myocardial tomography.

Authors:  E V Garcia; K Van Train; J Maddahi; F Prigent; J Friedman; J Areeda; A Waxman; D S Berman
Journal:  J Nucl Med       Date:  1985-01       Impact factor: 10.057

9.  Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification.

Authors:  R Hachamovitch; D S Berman; H Kiat; I Cohen; J A Cabico; J Friedman; G A Diamond
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

10.  Automatic quantification of myocardial perfusion stress-rest change: a new measure of ischemia.

Authors:  Piotr J Slomka; Hidetaka Nishina; Daniel S Berman; Xingping Kang; John D Friedman; Sean W Hayes; Usaf E Aladl; Guido Germano
Journal:  J Nucl Med       Date:  2004-02       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.